Hot Stocks: Brokerage view on BPCL, Sun Pharma, Thermax, Shree Cement and Power Grid

Top brokerage firms have released their recommendations for various companies. BofA Securities maintained an underperform rating on BPCL and Citi maintained a buy rating on Sun Pharma and Power Grid. Goldman Sachs retained its sell rating on Thermax, while Jefferies issued a hold rating on Shree Cement. Despite BPCL’s Rs 7,840 crore Q4 PAT, BofA Securities maintained a target price of Rs 315. Citi believes that Sun Pharma is among the top picks in the Indian Pharma space.